Comment from The Geneva Foundation, HHS-OPHS-2018-0021, HHS-OPHS-2018-0021-0001, N/A
The Geneva FoundationOtherIndividual
Summary: The commenter is providing a clinical trial consent form for a study on Ozanimod for Crohn's disease. This is a submission of a document rather than a comment expressing a position on the proposed federal action.
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn’s Disease - BAMC